CAMpania PugliA bRanch Iliaco

Last updated: April 23, 2025
Sponsor: Federico II University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Aneurysm

Treatment

Evar

Clinical Study ID

NCT06946381
CAMPARI
  • All Genders

Study Summary

Spontaneus Multicentric Observational registry to investigate the medium and long-term performances of the Iliac E-liac Branch Device from Artivion for treatment of Aortoiliac aneurysms in a real-world consecutive patients cohort.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • An aortoiliac or aortic aneurysm of surgical interest based on the most recent localguidelines treated with the E-liac stent-graft system, alone or in combination withother devices

Exclusion

Exclusion Criteria:

  • Patient's refusal to be enrolled in the registry

  • Patient treated with devices not including the E-liac stent-graft system

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Evar
Phase:
Study Start date:
January 01, 2015
Estimated Completion Date:
January 01, 2028

Connect with a study center

  • Azienda ospedaliero-universitaria consorziale policlinico di Bari

    Bari, BA
    Italy

    Active - Recruiting

  • Azienda Ospedaliera Universitaria Federico II

    Naples,
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.